In light of these considerations, we tested the hypothesis that FA effectively reduces DOXO‐induced cardiomyopathy in a mouse model of acute DOXO administration by modulating eNOS and preserving mitochondrial structure and function. The gene discussed is NOS3; the disease is cardiomyopathy.